About CD Pharma India Private Limited
Data last updated:
CD Pharma India Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Actial Farmaceutica S.Rl. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 May 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC126551. Its GSTIN is 07AACCC4315K1ZT (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Giacomo Gori and Maurizio Martinetti.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P 10 Ground Floor Green Park Extension, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2025, the company reported a revenue of ₹11 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.52 Lakh (net margin 13.8%) and EBITDA of ₹1.83 Lakh (EBITDA margin 16.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 21% over five years.
Court records list 10 cases involving the company, including 6 filed by the company and 4 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vsl3pharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressP 10 Ground Floor Green Park Extension, New Delhi, Delhi, India – 110016
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of CD Pharma India Private Limited
The main business activity of CD Pharma India is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of CD Pharma India Private Limited FY 2025 filings available
CD Pharma India Private Limited reported revenue of ₹11 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of CD Pharma India Private Limited
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 21%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of CD Pharma India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.83 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.52 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of CD Pharma India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 13.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of CD Pharma India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of CD Pharma India Private Limited
CD Pharma India has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Giacomo Gori | Director | 01 Dec 2015 | 10 Years 10 Months | Current |
| Maurizio Martinetti | Director | 01 Dec 2015 | 10 Years 10 Months | Current |
| Luca Aurelio Guarna | Director | 01 Dec 2015 | 10 Years 10 Months | Current |
| Ajaya Chand Also directs: Uniparts India Limited | Director | 01 Dec 2015 | 10 Years 10 Months | Current |
Peer Comparison of CD Pharma India Private Limited
CD Pharma India Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Supplements). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Puriteo Hygiene Private Limited | ₹12.08 Lakh (FY 2024) | •••• | •••• | 3697.0% | •••• | Ahmedabad, Gujarat, India |
| Tatvabodh Fitness Town (OPC) Private Limited | ₹11.77 Lakh (FY 2023) | •••• | •••• | 150.0% | •••• | Bhagalpur, Bihar, India |
| Datti Nutraceuticals Private Limited | ₹11.24 Lakh (FY 2023) | •••• | •••• | -25.0% | •••• | Hyderabad, Telangana, India |
| Trigonella Labs Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | -72.0% | •••• | Pune, Maharashtra, India |
| Dr H C Raheja Health Care Private Limited | ₹11.04 Lakh (FY 2021) | •••• | •••• | -2.0% | •••• | Lucknow, Uttar Pradesh, India |
| CD Pharma India Private Limited this company | ₹11 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Glyzy Technologies Private Limited | ₹10.94 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Bangalore, Karnataka, India |
| Akravi Private Limited | ₹10.74 Lakh (FY 2025) | •••• | •••• | -91.0% | •••• | New Delhi, Delhi, India |
| Casmolife Universal Private Limited | ₹10.42 Lakh (FY 2024) | •••• | •••• | 364.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Metabolic Nutrition Private Limited | ₹10.41 Lakh (FY 2025) | •••• | •••• | 76.0% | •••• | Rajkot, Gujarat, India |
| Stamin Millennium Nutraceuticals Private Limited | ₹10.3 Lakh (FY 2022) | •••• | •••• | 731.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below CD Pharma India by revenue in the Healthcare industry (Preventive Healthcare Supplements), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of CD Pharma India Private Limited
CD Pharma India Private Limited is audited by JAIKUMAR TEJWANI & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAIKUMAR TEJWANI & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of CD Pharma India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of CD Pharma India Private Limited
CD Pharma India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of CD Pharma India Private Limited
CD Pharma India Private Limited has 10 court cases on record: 6 filed by CD Pharma India, 4 filed against it. 2 cases are pending and 8 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 2 | 1 |
| Supreme Court | 2 | 1 | 0 |
| District courts | 2 | 1 | 1 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Criminal case | Filed against the company by Next Gen Pharma India Private Limited | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Next Gen Pharma India Private Limited | Pending |
| High Court of Delhi | Court case (FAO(OS) (COMM)) | Filed against the company by Next Gen Pharma India Private Limited | Disposed |
| Supreme Court | Special leave petition | Filed against the company by Next Gen Pharma India Private Limited | Disposed |
| District court, South, Delhi | Revision petition | Filed by the company against State | Disposed |
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at CD Pharma India Private Limited
Employment history and EPFO contributions of people linked to CD Pharma India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on CD Pharma India Private Limited
CD Pharma India Private Limited has 7 board changes on record since 2012: 4 appointments and 3 cessations. The latest: Claudio De Simone ceased to be Director on 30 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for CD Pharma India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by CD Pharma India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of CD Pharma India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of CD Pharma India Private Limited
CD Pharma India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCC4315K1ZT | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of CD Pharma India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CD Pharma India Private Limited
CD Pharma India is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 May 2004 (22+ years old) and is registered under CIN U24232DL2004PTC126551.
CD Pharma India reported revenue of ₹11 Lakh for FY 2025 (up 6% YoY).
CD Pharma India has 4 current directors:
- Giacomo Gori - Director
- Maurizio Martinetti - Director
- Luca Aurelio Guarna - Director
- Ajaya Chand - Director
CD Pharma India reported a net profit of ₹1.52 Lakh (net margin 13.8%) and EBITDA of ₹1.83 Lakh (EBITDA margin 16.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of CD Pharma India is -6% over three years and -21% over five years. In the latest year (FY 2025) revenue rose 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of CD Pharma India is 07AACCC4315K1ZT, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of CD Pharma India is U24232DL2004PTC126551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CD Pharma India has 10 court cases on record: 6 filed by the company and 4 filed against it. 2 are pending. Most are in the high courts.
CD Pharma India was incorporated on 25 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of CD Pharma India by revenue are Puriteo Hygiene Private Limited, Tatvabodh Fitness Town (OPC) Private Limited, Datti Nutraceuticals Private Limited, Trigonella Labs Private Limited, Dr H C Raheja Health Care Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Supplements).
Claudio De Simone ceased to be Director on 30 Sep 2016. Kanwaldeep Singh Chadha ceased to be Director on 01 Jun 2016. Ajaya Chand was appointed as Director on 01 Dec 2015. CD Pharma India has 7 board changes on record in total.